Ellis Investment Partners’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-6,377
Closed -$56K – 532
2022
Q3
$56K Buy
6,377
+8
+0.1% +$92 0.02% 377
2022
Q2
$65K Buy
6,369
+1,403
+28% +$20.8K 0.02% 369
2022
Q1
$103K Buy
4,966
+195
+4% +$4.25K 0.02% 311
2021
Q4
$122K Buy
4,771
+1,295
+37% +$35.8K 0.03% 289
2021
Q3
$109K Buy
3,476
+1,500
+76% +$52K 0.03% 290
2021
Q2
$79K Buy
1,976
+426
+27% +$17.3K 0.02% 338
2021
Q1
$66K Buy
1,550
+968
+166% +$44.6K 0.02% 351
2020
Q4
$21K Buy
+582
New +$17.4K 0.01% 472

Other funds holding MSOS

Ellis Investment Partners's MSOS Position: Q4 2022 in Review

Ellis Investment Partners sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q4 2022, closing a stake of 6,377 shares — an estimated $56K sold.

Ellis Investment Partners first reported a position in MSOS in Q4 2020 and held it in 8 quarters. The position peaked at $122K in Q4 2021. 176 funds tracked by Wall St. Rank hold MSOS as of Q4 2022.

  • Ellis Investment Partners reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 6,377 AdvisorShares Pure US Cannabis ETF shares in Q4 2022, an estimated $56K.
  • Ellis Investment Partners first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2020 and held it in 8 quarters.
  • Ellis Investment Partners's AdvisorShares Pure US Cannabis ETF position peaked at $122K in Q4 2021.
  • 176 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.